s6y

Alaunos Therapeutics, Inc.

Ticker
TCRT
CIK
1107421
Industry
Pharmaceutical Preparations
Formerly
ZIOPHARM ONCOLOGY INC, EASYWEB INC

Financials 88

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K/A Annual Report for period ending Dec 31, 2025
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K/A Annual Report for period ending Dec 31, 2024
  10. 10-K Annual Report for period ending Dec 31, 2024

All 88 financials filings

News 360

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 360 news filings

Ownership 568

  1. 3 Initial statement of beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 568 ownership filings

Prospectus 77

  1. S-3 Registration statement for specified transactions by certain issuers
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. 424B8 Prospectus filed pursuant to Rule 424(b)(8)
  5. S-3/A Registration statement for specified transactions by certain issuers
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. S-3/A Registration statement for specified transactions by certain issuers
  8. S-3/A Registration statement for specified transactions by certain issuers
  9. S-3 Registration statement for specified transactions by certain issuers
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 77 prospectus filings

Proxies 87

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 87 proxies filings

Other 119

  1. SCHEDULE 13D
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D/A
  7. SCHEDULE 13D
  8. SCHEDULE 13G/A
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. UPLOAD Letter (PDF)

All 119 other filings